Press Releases

Sentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases

Zokinvy is approved in the U.S. (2020), European Union and Great Britain (2022), and Japan (2024) for the treatment of progeria, a collection of ultra-rare, fatal, genetic premature aging diseases that accelerate mortality in young patients

SOLANA BEACH, Calif. and AHMEDABAD, India and PALO ALTO, Calif., May 3,... (continue reading...)

WALTHAM, Mass., May 3, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel Disease ("IBD"), today announced that Spyre's independent Compensation Committee of the Board of Directors approved the grants of stock options to purchase an... (continue reading...)

VANCOUVER, BC, May 3, 2024 /PRNewswire/ - Galiano Gold Inc. ("Galiano" or the "Company") (TSX: GAU) (NYSE American: GAU) advises its Annual General Meeting of shareholders ("AGM") will be held virtually on Thursday, June 13, 2024, at 10:00 am PDT. Shareholders who intend to participate in the AGM should refer to the Company's management information circular (the "Proxy Circular") for details regarding how to participate.

... (continue reading...)

IRVING, Texas, May 3, 2024 /PRNewswire/ -- Caterpillar Inc. (NYSE: CAT) will hold a virtual annual shareholder meeting on Wednesday, June 12, 2024, at 8 a.m. CDT.

Shareholders owning Caterpillar common stock at the close of business on April 15, 2024, or their legal proxy holders, are entitled to participate, submit questions and vote on several items... (continue reading...)

HAWTHORNE, Calif.--(BUSINESS WIRE)-- OSI Systems, Inc. (the "Company") (NASDAQ: OSIS) announced today that Chairman and Chief Executive Officer Deepak Chopra has informed the Company’s Board of Directors of his plans to retire from his roles as President and Chief Executive Officer by the end of the current calendar year, after the appointment of a successor. Following his retirement as President and CEO, Mr. Chopra will continue to work with the Company as... (continue reading...)